A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers

A novel proteotoxic combination therapy for EGFR+ and HER2+ cancersA novel proteotoxic combination therapy for EGFR+ and HER2+ cancers, Published online: 04 February 2019; doi:10.1038/s41388-019-0717-6A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers

Source: Oncogene - February 4, 2019 Category: Cancer & Oncology Authors: Mengxiong Wang Renan B. Ferreira Mary E. Law Bradley J. Davis Elham Yaaghubi Amanda F. Ghilardi Abhisheak Sharma Bonnie A. Avery Edgardo Rodriguez Chi-Wu Chiang Satya Narayan Coy D. Heldermon Ronald K. Castellano Brian K. Law Source Type: research